Labiana Health, S.A. (BME:LAB)

Labiana Health Statistics

Total Valuation

Labiana Health has a market cap or net worth of EUR 29.85 million. The enterprise value is 57.40 million.

Market Cap	29.85M
Enterprise Value	57.40M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Labiana Health has 7.04 million shares outstanding.

Current Share Class	7.04M
Shares Outstanding	7.04M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.48%
Float	n/a

Valuation Ratios

The trailing PE ratio is 117.78 and the forward PE ratio is 7.85.

PE Ratio	117.78
Forward PE	7.85
PS Ratio	0.44
PB Ratio	11.62
P/TBV Ratio	9.33
P/FCF Ratio	7.15
P/OCF Ratio	4.15
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.96, with an EV/FCF ratio of 13.74.

EV / Earnings	226.46
EV / Sales	0.85
EV / EBITDA	7.96
EV / EBIT	11.29
EV / FCF	13.74

Financial Position

The company has a current ratio of 1.30, with a Debt / Equity ratio of 13.78.

Current Ratio	1.30
Quick Ratio	0.81
Debt / Equity	13.78
Debt / EBITDA	4.91
Debt / FCF	8.47
Interest Coverage	1.05

Financial Efficiency

Return on equity (ROE) is 6.92% and return on invested capital (ROIC) is 7.65%.

Return on Equity (ROE)	6.92%
Return on Assets (ROA)	5.72%
Return on Invested Capital (ROIC)	7.65%
Return on Capital Employed (ROCE)	17.03%
Revenue Per Employee	182,587
Profits Per Employee	687
Employee Count	369
Asset Turnover	1.21
Inventory Turnover	2.47

Taxes

Income Tax	-236,502
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +72.13% in the last 52 weeks. The beta is 0.23, so Labiana Health's price volatility has been lower than the market average.

Beta (5Y)	0.23
52-Week Price Change	+72.13%
50-Day Moving Average	4.12
200-Day Moving Average	3.50
Relative Strength Index (RSI)	54.46
Average Volume (20 Days)	709

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Labiana Health had revenue of EUR 67.37 million and earned 253,453 in profits.

Revenue	67.37M
Gross Profit	38.91M
Operating Income	5.08M
Pretax Income	-29,992
Net Income	253,453
EBITDA	7.21M
EBIT	5.08M
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has 6.90 million in cash and 35.39 million in debt, giving a net cash position of -28.49 million or -4.05 per share.

Cash & Cash Equivalents	6.90M
Total Debt	35.39M
Net Cash	-28.49M
Net Cash Per Share	-4.05
Equity (Book Value)	2.57M
Book Value Per Share	n/a
Working Capital	6.54M

Cash Flow

In the last 12 months, operating cash flow was 7.19 million and capital expenditures -3.02 million, giving a free cash flow of 4.18 million.

Operating Cash Flow	7.19M
Capital Expenditures	-3.02M
Free Cash Flow	4.18M
FCF Per Share	0.59

Margins

Gross margin is 57.75%, with operating and profit margins of 7.55% and 0.38%.

Gross Margin	57.75%
Operating Margin	7.55%
Pretax Margin	-0.04%
Profit Margin	0.38%
EBITDA Margin	10.70%
EBIT Margin	7.55%
FCF Margin	6.20%

Dividends & Yields

Labiana Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	0.85%
FCF Yield	13.99%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Labiana Health has an Altman Z-Score of 2.1 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.1
Piotroski F-Score	5